Bioatla Stock Market Value
| BCAB Stock | USD 0.16 0.02 11.11% |
| Symbol | Bioatla |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. Projected growth potential of Bioatla fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Bioatla assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bioatla's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bioatla should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bioatla's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Bioatla 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioatla's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioatla.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Bioatla on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Bioatla or generate 0.0% return on investment in Bioatla over 90 days. Bioatla is related to or competes with Celularity, PolyPid, Annovis Bio, Reviva Pharmaceuticals, Evaxion Biotech, BioXcel Therapeutics, and Generation Bio. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics f... More
Bioatla Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioatla's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioatla upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 66.15 | |||
| Value At Risk | (18.87) | |||
| Potential Upside | 15.28 |
Bioatla Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioatla's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioatla's standard deviation. In reality, there are many statistical measures that can use Bioatla historical prices to predict the future Bioatla's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (2.54) | |||
| Treynor Ratio | 0.9475 |
Bioatla February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 0.9575 | |||
| Mean Deviation | 7.54 | |||
| Coefficient Of Variation | (642.94) | |||
| Standard Deviation | 10.43 | |||
| Variance | 108.85 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (2.54) | |||
| Treynor Ratio | 0.9475 | |||
| Maximum Drawdown | 66.15 | |||
| Value At Risk | (18.87) | |||
| Potential Upside | 15.28 | |||
| Skewness | (0.19) | |||
| Kurtosis | 2.17 |
Bioatla Backtested Returns
Bioatla secures Sharpe Ratio (or Efficiency) of -0.19, which signifies that the company had a -0.19 % return per unit of risk over the last 3 months. Bioatla exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bioatla's Risk Adjusted Performance of (0.12), mean deviation of 7.54, and Standard Deviation of 10.43 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.72, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Bioatla are expected to decrease by larger amounts. On the other hand, during market turmoil, Bioatla is expected to outperform it. At this point, Bioatla has a negative expected return of -2.02%. Please make sure to confirm Bioatla's total risk alpha, skewness, rate of daily change, as well as the relationship between the maximum drawdown and accumulation distribution , to decide if Bioatla performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.58 |
Modest predictability
Bioatla has modest predictability. Overlapping area represents the amount of predictability between Bioatla time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioatla price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Bioatla price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:Check out Bioatla Correlation, Bioatla Volatility and Bioatla Performance module to complement your research on Bioatla. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Bioatla technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.